Nicholas Butowski

8PUBLICATIONS
161CO-AUTHORS
Tumour immunologyMolecular targetsMining, energy and natural resources lawPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 13, 2026
IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.

Jacob S Young, Nam Woo Cho, Calixto-Hope G Lucas

|Feb 06, 2026
A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Jiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Feb 09, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.

Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia

|Aug 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji

|Jan 04, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.

Shawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips

Pageof 2

Frequent Collaborators

3 joint publications

Jennie W Taylor

3 joint publications

John F de Groot

3 joint publications

Patrick Y Wen

2 joint publications

Andrew B Lassman